Home Compliance The DOJ’s Focus on Clinical Trial Enforcement: An Ounce of Prevention Is... ComplianceExpert OpinionNews The DOJ’s Focus on Clinical Trial Enforcement: An Ounce of Prevention Is Better Than an Enforcement Action Cure May 9, 2022 32 Share FacebookLinkedinTwitter ESB Professional | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance “Please Pay No Attention to the Microphone:” DOJ Announces New Program Offering Protections to Criminal Whistleblowers Compliance Money Makes the Compliance Go Around Compliance Core FCPA Beliefs